CEPIUpdates from CEPI
100 Days to Outrace the Next Pandemic
What will it take to create safe and effective vaccines in 100 days? Watch this session from the World Economic Forum to learn how CEPI is accelerating the development of vaccines and enabling equitable access during outbreaks.
Watch the video
CEPI and Institut Pasteur de Dakar announce 10-year partnership
With an investment representing $50 million over 10 years, this partnership between CEPI and Institut Pasteur de Dakar will boost manufacturing of affordable vaccines for the Global South.
Read more
CEPI invests to advance development of Vaxxas’ needle-free vaccine-patch delivery technology
CEPI and Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, have signed a partnership agreement to advance the development of Vaxxas’ needle-free vaccine-patch delivery technology. This project aims to end the need for frozen storage and improve vaccine development in response to outbreak threats.
Read more
CEPI to partner with Belgium universities to enhance global pandemic preparedness
CEPI has entered into strategic partnerships with the Belgian Universities KU Leuven and the University of Antwerp to collaborate in areas that will contribute to improved global pandemic preparedness.
Read more
Real-world effectiveness of COVID-19 vaccines
In this article Mario Christodoulou, CEPI’s Senior Communications and Advocacy Manager, discusses why real-world vaccine-effectiveness studies are essential to inform vaccine roll-out strategies and how CEPI is supporting such studies.
Read more
CEPI announces partnership with Tiba Biotech
CEPI and Tiba Biotech, a preclinical biopharmaceutical company, have announced a new partnership agreement to evaluate Tiba Biotech’s next-generation RNA vaccine platform technology to respond to ‘Disease X’.
Read more
Stabilised mRNA vaccine tech aims to end need for frozen storage and improve access
CEPI and Netherlands-based 20Med have partnership to advance development of 20Med’s bioresponsive polymeric nanoparticle platform for mRNA stabilisation and delivery.
Read more
